NCT04149691 2024-02-07
Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies
Celon Pharma SA
Phase 1 Unknown
Celon Pharma SA
Multitude Therapeutics Inc.
Sichuan University
Peking University
Evolve Biologics
University Hospital, Strasbourg, France